DE:RV7 / Halozyme Therapeutics, Inc. - Aktieskærme

Halozyme Therapeutics, Inc.
DE ˙ DB ˙ US40637H1095
65,92 € ↑1,36 (2,11%)
2025-09-12
DEL PRIS
RV7 / Halozyme Therapeutics, Inc. - Aktieskærme

Normalt vil denne side vise en liste over aktieskærmresultater, der indeholder denne sikkerhed.
Men den liste er i øjeblikket tom.

Opret en ny skærm Se eksisterende skærme
Other Listings
IT:1HALO 64,00 €
MX:HALO
US:HALO 76,90 $
GB:0J2O
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista